ArticleFrontiers in neurology

Serum albumin-to-creatinine ratio as a novel and cost-effective biomarker for silent cerebral infarction: a retrospective cohort study.

Mustafa Mazıcan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.